Clinical and prognostic implications of an immune-related risk model based on TP53 status in lung adenocarcinoma.

导出 OA

翻译打印收藏纠错

作者： Xuming,Song ^[1] ; Qiang,Chen ^[2] ; Jifan,Wang ^[3] ; Qixing,Mao ^[4] ; Wenjie,Xia ^[5] ; Lin,Xu ^[1] ; Feng,Jiang ^[2] ; Gaochao,Dong ^[3]

作者单位： The Affiliated Cancer Hospital of Nanjing Medical University, Nanjing, China. ^[1] Department of Thoracic Surgery, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, Nanjing, China. ^[2] Jiangsu Key Laboratory of Molecular and Translational Cancer Research, Cancer Institute of Jiangsu Province, Nanjing, China. ^[3] The Fourth Clinical College of Nanjing Medical University, Nanjing, China. ^[4] XuZhou Central Hospital, Xuzhou, China. ^[5]

关键词 TP53?mutation immune profile immune prognostic model lung adenocarcinoma

主题词基因表达调控, 肿瘤(Gene Expression Regulation, Neoplastic);人类(Humans);肺肿瘤(Lung Neoplasms);预后(Prognosis);肿瘤微环境(Tumor Microenvironment);肿瘤抑制蛋白质p53(Tumor Suppressor Protein p53)

DOI 10.1111/jcmm.17097

PMID 34877770

发布时间 2022-07-14

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交